85 related articles for article (PubMed ID: 1728123)
1. Immunohistochemical study of pancreatic cystadenocarcinoma.
Motojima K; Tomioka T; Tsunoda T; Kanamatsu T
Am J Gastroenterol; 1992 Jan; 87(1):43-7. PubMed ID: 1728123
[TBL] [Abstract][Full Text] [Related]
2. Two cases of pancreatic cystadenocarcinoma with elevated CA 19-9 levels in the cystic fluid in comparison with two cases of pancreatic cystadenoma.
Nishida K; Shiga K; Kato K; Kunihiro K; Fujii T; Tomii T; Yamamoto H; Yamane E; Nishioka B; Yoshikawa T
Hepatogastroenterology; 1989 Dec; 36(6):442-5. PubMed ID: 2693299
[TBL] [Abstract][Full Text] [Related]
3. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.
Devaney K; Goodman ZD; Ishak KG
Am J Surg Pathol; 1994 Nov; 18(11):1078-91. PubMed ID: 7943529
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
[TBL] [Abstract][Full Text] [Related]
5. Cystic neoplasms of the pancreas.
Kerlin DL; Frey CF; Bodai BI; Twomey PL; Ruebner B
Surg Gynecol Obstet; 1987 Dec; 165(6):475-8. PubMed ID: 2446398
[TBL] [Abstract][Full Text] [Related]
6. Mucinous cystic tumor of the pancreas: immunohistochemical assessment of "ovarian-type stroma".
Izumo A; Yamaguchi K; Eguchi T; Nishiyama K; Yamamoto H; Yonemasu H; Yao T; Tanaka M; Tsuneyoshi M
Oncol Rep; 2003; 10(3):515-25. PubMed ID: 12684617
[TBL] [Abstract][Full Text] [Related]
7. Presentation and management of pancreatic cystic neoplasms.
Gourgiotis S; Germanos S; Ridolfini MP
J Clin Gastroenterol; 2007 Jul; 41(6):599-608. PubMed ID: 17577117
[TBL] [Abstract][Full Text] [Related]
8. Cystic neoplasms of the exocrine pancreas.
Campbell F; Azadeh B
Histopathology; 2008 Apr; 52(5):539-51. PubMed ID: 17903202
[TBL] [Abstract][Full Text] [Related]
9. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
[TBL] [Abstract][Full Text] [Related]
10. Loss of p27Kip1 expression independently predicts poor prognosis for patients with resectable pancreatic adenocarcinoma.
Lu CD; Morita S; Ishibashi T; Hara H; Isozaki H; Tanigawa N
Cancer; 1999 Mar; 85(6):1250-60. PubMed ID: 10189129
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical similarities between pancreatic mucinous cystic tumor and ovarian mucinous cystic tumor.
Suzuki Y; Sugiyama M; Abe N; Fujioka Y; Atomi Y
Pancreas; 2008 Jan; 36(1):e40-6. PubMed ID: 18192871
[TBL] [Abstract][Full Text] [Related]
12. Serum concentration and immunohistochemical localization of SPan-1 antigen in pancreatic cancer. A comparison with CA19-9 antigen.
Takeda S; Nakao A; Ichihara T; Suzuki Y; Nonami T; Harada A; Koshikawa T; Takagi H
Hepatogastroenterology; 1991 Apr; 38(2):143-8. PubMed ID: 1855772
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cystic islet-cell tumors. Clinical and pathologic features in two cases with cyst fluid analysis.
Weissmann D; Lewandrowski K; Godine J; Centeno B; Warshaw A
Int J Pancreatol; 1994 Feb; 15(1):75-9. PubMed ID: 8195644
[TBL] [Abstract][Full Text] [Related]
14. [A mucinous cystadenocarcinoma of the pancreas. A clinical and histopathological contribution].
Gentile G; Pizzolitto S; Binotto F
Minerva Chir; 1991 Apr; 46(7):327-34. PubMed ID: 1866040
[TBL] [Abstract][Full Text] [Related]
15. [Giant cystadenocarcinoma of pancreatic origin and supra-mesocolic topography].
Tassin X; Nguyen TA; Godlewski G; Ould Said A; Joujoux JM; Dubois JB
Ann Gastroenterol Hepatol (Paris); 1991 Oct; 27(5):207-10. PubMed ID: 1746873
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
Sugano K; Okura H
Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
[No Abstract] [Full Text] [Related]
17. Cyst fluid carcinoembryonic antigen in the investigation of cystic neuroendocrine tumors of the pancreas.
Croagh D; Forde C; Boulton R; Mahon B
Gastrointest Endosc; 2011 Dec; 74(6):1413-6. PubMed ID: 22136785
[No Abstract] [Full Text] [Related]
18. [Pancreatic cystadenocarcinoma revealed by an acute pancreatitis and exploratory surgery. A rare case report].
Bedioui H; Moalla N-Manai MH; Chahbani S; Gordah A; Essoussi M; Ben Aleya M
Tunis Med; 2003 Aug; 81(8):586-90. PubMed ID: 14608744
[TBL] [Abstract][Full Text] [Related]
19. [Value of biological markers in the diagnosis and monitoring of cystadenocarcinoma].
Bidart JM; Bellet D
Rev Prat; 1989 Nov; 39(26):2317-20. PubMed ID: 2595221
[TBL] [Abstract][Full Text] [Related]
20. CA54/61 as a marker for epithelial ovarian cancer.
Nozawa S; Aoki D; Yajima M; Tsukazaki K; Kobayashi T; Kimura E; Terashima Y; Inaba N; Takamizawa H; Negishi Y
Cancer Res; 1992 Mar; 52(5):1205-9. PubMed ID: 1737381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
